How stress changes brain signals that control reward and motivation
The Impact of Stress-induced KCC2 Downregulation on Mesolimbic Dopamine Signaling and Reward Processing
['FUNDING_R01'] · GEORGETOWN UNIVERSITY · NIH-11237167
This work looks at how stress reduces a brain protein called KCC2 and alters reward circuit signals in ways that may relate to depression and other stress-linked mental health problems.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | GEORGETOWN UNIVERSITY (nih funded) |
| Locations | 1 site (WASHINGTON, UNITED STATES) |
| Trial ID | NIH-11237167 on ClinicalTrials.gov |
What this research studies
Researchers will use rat models to see how stress lowers KCC2 in inhibitory (GABA) neurons in the ventral tegmental area and how that change affects dopamine signaling to the nucleus accumbens. They will record both steady (tonic) and burst (phasic) dopamine activity and measure GABA input onto dopamine neurons that project to different parts of the accumbens (core, medial shell, lateral shell). The team will link these circuit changes to altered reward processing that can drive depression-like behaviors in animals. Results will be used to identify potential molecular or circuit targets for therapies that restore normal reward signaling.
Who could benefit from this research
Good fit: People with stress-related mood problems such as major depression, PTSD, or prominent loss of pleasure (anhedonia) are the groups most likely to benefit from therapies informed by this research.
Not a fit: Patients whose problems are unrelated to stress-linked reward-circuit dysfunction (for example, purely structural brain disease or non-neuropsychiatric conditions) are unlikely to see direct benefit from this preclinical work.
Why it matters
Potential benefit: If successful, this work could point to new targets for treatments to reduce anhedonia and other stress-related symptoms by restoring inhibitory balance in reward circuits.
How similar studies have performed: Prior animal studies show that restoring KCC2 or correcting GABAergic imbalance can reverse some stress-related neural and behavioral changes, but translation to effective human treatments remains unproven.
Where this research is happening
WASHINGTON, UNITED STATES
- GEORGETOWN UNIVERSITY — WASHINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OSTROUMOV, ALEXEY — GEORGETOWN UNIVERSITY
- Study coordinator: OSTROUMOV, ALEXEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.